Details of the Target
General Information of Target
Target ID | LDTP03097 | |||||
---|---|---|---|---|---|---|
Target Name | Ribose-phosphate pyrophosphokinase 3 (PRPS1L1) | |||||
Gene Name | PRPS1L1 | |||||
Gene ID | 221823 | |||||
Synonyms |
PRPS3; PRPSL; Ribose-phosphate pyrophosphokinase 3; EC 2.7.6.1; Phosphoribosyl pyrophosphate synthase 1-like 1; PRPS1-like 1; Phosphoribosyl pyrophosphate synthase III; PRS-III |
|||||
3D Structure | ||||||
Sequence |
MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIDESVRGEDVYIVQSGC
GEINDSLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRSPISAKLVANMLSIAG ADHIITMDLHASQIQGFFDIPVDNLYAEPTVLKWIRENIPEWKNCIIVSPDAGGAKRVTS IADQLNVDFALIHKERKKANEVDCIVLVGDVNDRVAILVDDMADTCVTICLAADKLLSAG ATRVYAILTHGIFSGPAISRINTACFEAVVVTNTIPQDEKMKHCSKIRVIDISMILAEAI RRTHNGESVSYLFSHVPL |
|||||
Target Bioclass |
Enzyme
|
|||||
Family |
Ribose-phosphate pyrophosphokinase family
|
|||||
Function | Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis. | |||||
Uniprot ID | ||||||
Ensemble ID | ||||||
HGNC ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
TH211 Probe Info |
![]() |
Y94(20.00) | LDD0257 | [1] | |
STPyne Probe Info |
![]() |
K194(4.35); K282(5.88) | LDD0277 | [2] | |
BTD Probe Info |
![]() |
C165(1.15) | LDD1699 | [3] | |
IPM Probe Info |
![]() |
C91(0.00); C165(0.00) | LDD0241 | [4] | |
DBIA Probe Info |
![]() |
C91(0.92) | LDD3310 | [5] | |
IA-alkyne Probe Info |
![]() |
C284(20.00) | LDD0371 | [6] | |
HHS-465 Probe Info |
![]() |
Y94(1.79) | LDD2237 | [7] | |
PF-06672131 Probe Info |
![]() |
C91(0.00); C165(0.00) | LDD0152 | [8] | |
Acrolein Probe Info |
![]() |
N.A. | LDD0217 | [9] | |
Methacrolein Probe Info |
![]() |
N.A. | LDD0218 | [9] | |
AOyne Probe Info |
![]() |
6.10 | LDD0443 | [10] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DA-2 Probe Info |
![]() |
N.A. | LDD0073 | [11] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0524 | 2-Cyano-N-(2-morpholin-4-yl-ethyl)-acetamide | MDA-MB-231 | C284(1.41) | LDD2117 | [3] |
LDCM0539 | 3-(4-Isopropylpiperazin-1-yl)-3-oxopropanenitrile | MDA-MB-231 | C165(0.88) | LDD2132 | [3] |
LDCM0538 | 4-(Cyanoacetyl)morpholine | MDA-MB-231 | C165(0.57) | LDD2131 | [3] |
LDCM0025 | 4SU-RNA | HEK-293T | C284(20.00) | LDD0371 | [6] |
LDCM0026 | 4SU-RNA+native RNA | HEK-293T | C284(20.00) | LDD0372 | [6] |
LDCM0545 | Acetamide | MDA-MB-231 | C165(1.07) | LDD2138 | [3] |
LDCM0498 | BS-3668 | MDA-MB-231 | C165(1.03) | LDD2091 | [3] |
LDCM0108 | Chloroacetamide | HeLa | N.A. | LDD0222 | [9] |
LDCM0625 | F8 | Ramos | C165(0.70) | LDD2187 | [12] |
LDCM0572 | Fragment10 | Ramos | C165(0.58) | LDD2189 | [12] |
LDCM0573 | Fragment11 | Ramos | C165(0.38) | LDD2190 | [12] |
LDCM0574 | Fragment12 | Ramos | C165(0.78) | LDD2191 | [12] |
LDCM0575 | Fragment13 | Ramos | C165(1.10) | LDD2192 | [12] |
LDCM0576 | Fragment14 | Ramos | C165(0.84) | LDD2193 | [12] |
LDCM0579 | Fragment20 | Ramos | C165(0.60) | LDD2194 | [12] |
LDCM0580 | Fragment21 | Ramos | C165(0.99) | LDD2195 | [12] |
LDCM0582 | Fragment23 | Ramos | C165(0.67) | LDD2196 | [12] |
LDCM0578 | Fragment27 | Ramos | C165(1.07) | LDD2197 | [12] |
LDCM0586 | Fragment28 | Ramos | C165(0.82) | LDD2198 | [12] |
LDCM0588 | Fragment30 | Ramos | C165(1.00) | LDD2199 | [12] |
LDCM0589 | Fragment31 | Ramos | C165(1.03) | LDD2200 | [12] |
LDCM0590 | Fragment32 | Ramos | C165(0.56) | LDD2201 | [12] |
LDCM0468 | Fragment33 | Ramos | C165(0.92) | LDD2202 | [12] |
LDCM0596 | Fragment38 | Ramos | C165(0.93) | LDD2203 | [12] |
LDCM0566 | Fragment4 | Ramos | C165(0.63) | LDD2184 | [12] |
LDCM0610 | Fragment52 | Ramos | C165(1.47) | LDD2204 | [12] |
LDCM0614 | Fragment56 | Ramos | C165(1.15) | LDD2205 | [12] |
LDCM0569 | Fragment7 | Ramos | C165(0.59) | LDD2186 | [12] |
LDCM0571 | Fragment9 | Ramos | C165(0.61) | LDD2188 | [12] |
LDCM0107 | IAA | HeLa | N.A. | LDD0221 | [9] |
LDCM0022 | KB02 | Ramos | C165(0.42) | LDD2182 | [12] |
LDCM0023 | KB03 | Ramos | C165(0.68) | LDD2183 | [12] |
LDCM0024 | KB05 | COLO792 | C91(0.92) | LDD3310 | [5] |
LDCM0528 | N-(4-bromophenyl)-2-cyano-N-phenylacetamide | MDA-MB-231 | C165(1.20) | LDD2121 | [3] |
LDCM0514 | Nucleophilic fragment 20a | MDA-MB-231 | C165(0.91) | LDD2107 | [3] |
LDCM0516 | Nucleophilic fragment 21a | MDA-MB-231 | C284(0.59) | LDD2109 | [3] |
LDCM0526 | Nucleophilic fragment 26a | MDA-MB-231 | C165(1.29) | LDD2119 | [3] |
LDCM0530 | Nucleophilic fragment 28a | MDA-MB-231 | C165(1.00) | LDD2123 | [3] |
LDCM0540 | Nucleophilic fragment 35 | MDA-MB-231 | C165(0.64) | LDD2133 | [3] |
LDCM0543 | Nucleophilic fragment 38 | MDA-MB-231 | C284(1.22) | LDD2136 | [3] |
LDCM0544 | Nucleophilic fragment 39 | MDA-MB-231 | C284(1.13) | LDD2137 | [3] |
LDCM0550 | Nucleophilic fragment 5a | MDA-MB-231 | C165(1.56) | LDD2144 | [3] |
LDCM0554 | Nucleophilic fragment 7a | MDA-MB-231 | C165(0.64) | LDD2148 | [3] |
References